Subscribe
Magazine
Videos
Advertise
About Us
Smart Water Summit
Wastewater Summit
Drinking Water
Smart Water
Asset Management
Water Utility Management
Water Reuse
Global Thought Leaders
Podcast
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
WaterWorld Market Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Ketamine Treatment
Recent news which mentions Ketamine Treatment
Psychedelics Headlines: Magic Mushrooms For Sexual Wellbeing, The DEA's Stance, The Therapist's Role & More
January 08, 2024
Tickers
NEWS
OPTHF
PMBHF
Tags
Markets
psilocybin therapies
News
From
Benzinga
Psyched: Defense Dept.'s Ketamine Trial, Cybin's Psilocybin, Metabolic Disorders, Reform Update And More
December 05, 2023
Tickers
ATAI
CMND
CMPS
CYBN
Tags
IXHL
MNMD
ATAI
From
Benzinga
Super Model Chrissy Teigen Talks About Ketamine Therapy Session, Says She Saw 'Space & Time'
December 04, 2023
Tags
News
Psychedelics
Ketamine Treatment
From
Benzinga
Defense Dept. Funds Ketamine Study For PTSD Treatment In 600 Service Members & Veterans
November 27, 2023
Tickers
DOD
SEEL
Tags
Ketamine Treatment
Psychedelics
Cannabis
From
Benzinga
Johnson & Johnson's Q3 2023: $21.3B Rise In Sales, 'Sharpened Focus' On Innovation & Biotech Solutions
October 17, 2023
Tickers
JNJ
Tags
Ketamine Treatment
Psychedelics
News
From
Benzinga
Psyched: FDA Warning, DEA's Telehealth Extension, CA Gov's Veto, Congress On Kratom, M&As & More
October 16, 2023
Tickers
ATAI
CMPS
CYBN
DMTTF
Tags
News
CMPS
CYBN
From
Benzinga
PharmaTher Is 'One Step Closer To Being A Ketamine Leader' Due To FDA Acceptance
September 27, 2023
Tickers
PHRRF
Tags
Ketamine Treatment
Psychedelics
Health Care
From
Benzinga
PharmaTher Aims To Mitigate Ketamine Shortage With New FDA Application
September 06, 2023
Tickers
PHRRF
Tags
News
Abbreviated New Drug Application
Markets
From
Benzinga
Breaking Ground In Prevention & Relief Of Anxiety & PTSD: Silo Pharma' Nasal Formulation For Ketamine-Based Treatment
August 08, 2023
Tickers
SILO
Tags
Markets
News
Management
From
Benzinga
Awakn Life Sciences Becomes Pure R&D Biotech After Sale Of Norway Clinics
August 01, 2023
Tickers
AWKNF
Tags
Benzinga
Penny Stocks
Global
From
Benzinga
Ketamine News: PharmaTher Begins FDA Filing For KETARX Application, Stella Acquires Field Trip Assets
June 27, 2023
Tickers
FTHWF
PHRRF
Tags
FDA
Benzinga
Psychedelic/Assisted Therapies
From
Benzinga
Silo Pharma's New Ketamine Implant For Fibromyalgia And Chronic Pain Is In The Making
June 13, 2023
Tickers
SILO
TRYPF
Tags
Ketamine Treatment
Psychedelics
Market News
From
Benzinga
Seelos Therapeutics Positive Q1 Financials Make For 'The Most Important Year' In Company's History
May 16, 2023
Tickers
SEEL
Tags
Markets
Earnings
News
From
Benzinga
Stress-Related Mood Disorders And Alzheimer's: Can This Patented Ketamine Drug Help?
May 10, 2023
Tickers
SILO
Tags
News
Stress/Induced Disorders
Markets
From
Benzinga
Atai Advances R-Ketamine Through Phase 1 Bridging Study, Update And Near-Term Expectations
April 14, 2023
Tickers
ATAI
Tags
Ketamine Treatment
ATAI
Psychedelics
From
Benzinga
Ketamine Company Advances Parkinson's Treatment Through Final Stages Toward FDA Approval
March 30, 2023
Tickers
PHRRF
Tags
Parkinson's Disease
Ketamine Treatment
Psychedelics
From
Benzinga
Silo Pharma To Patent Novel Ketamine-Based Treatment For Chronic Condition
March 27, 2023
Tickers
SILO
Tags
News
USPTO
intellectual property
From
Benzinga
Breakthrough Treatment For PTSD? This Ketamine Cream Showing Promise In Alleviating Symptoms
March 22, 2023
Tickers
BWVI
Tags
News
NeuroDirect
Markets
From
Benzinga
Major Ketamine Clinics Chain Decides Not To Pursue Acquisition Deal
March 16, 2023
Tickers
BRAXF
IWINF
Tags
Markets
BRAXF
News
From
Benzinga
Awakn's First Licensing Partnership Deal In Europe Involves Chain Of Portuguese Clinics
February 22, 2023
Tickers
AWKNF
Tags
PTSD treatment
Benzinga
Penny Stocks
From
Benzinga
Novel Ketamine Topical Cream To Treat PTSD Gets First In-Human Trials
February 16, 2023
Tickers
BWVI
Tags
Top Stories
iNGENū
Management
From
Benzinga
Psychedelics For Alcohol Use Disorder: Awakn Opens European Clinic, FSD Launches R&D Program
February 14, 2023
Tickers
AWKNF
HUGE
Tags
Market News
Cannabis
Financing
From
Benzinga
Seelos Dosing Participants In Psychedelics Study, Seeks Japanese Subjects In Major Depression Therapy
February 07, 2023
Tickers
SEEL
Tags
Penny Stocks
Benzinga
Market News
From
Benzinga
PharmaTher Holdings Nabs New Orphan Drug Status, Discusses Further Fast-Track, Partners For MDMA Patch
February 03, 2023
Tickers
PHRRF
RVVTF
Tags
Orphan Drug Designation
RVVTF
Markets
From
Benzinga
Israeli Biotech Develops Ketamine Analogue To Treat Major Depression With Promising Results
January 31, 2023
Tickers
CMND
Tags
News
Markets
Next/Generation Psychedelics
From
Benzinga
FDA Green Lights New Study Testing IV Ketamine Infusion For Depressive Disorder
December 16, 2022
Tickers
EHVVF
Tags
News
clinical trials
Management
From
Benzinga
FDA OKs Ketamine For Treating Organ Transplant Injuries With 'Orphan Drug' Status
December 15, 2022
Tickers
PHRRF
Tags
Benzinga
FDA
Penny Stocks
From
Benzinga
Psychedelic-Assisted Therapies: Upcoming Moves In Montana, Colorado And Ontario
November 22, 2022
Tags
Psychedelic/Assisted Therapies
Benzinga
Market News
From
Benzinga
This New Psychedelic Therapy Program Will Accompany Patients In Their Healing Journey For A Whole Year
November 15, 2022
Tags
News
Psychedelics/Assisted Therapy
Ketamine Treatment
From
Benzinga
Novel Psychedelic Compound For The Treatment Of Fibromyalgia Begins Dosing In Safety Trial
November 11, 2022
Tickers
SILO
Tags
Markets
News
Legal
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.